Semaglutide microdosing conversations
GLP-1 pathway
A lower-dose semaglutide discussion may center on appetite regulation, food-noise questions, metabolic markers, side-effect history, and whether a gradual approach is clinically appropriate.
- Eligibility first
- Medication and contraindication review
- Follow-up plan if prescribed
